A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism
NCT04701203
Endocrine System Diseases, Hypoparathyroidism
San Francisco, California, United States
View Trial DetailsNCT Number: NCT03437174
Long-term conventional treatment of chronic hypoparathyroidism does not fully restore calcium homeostasis leading to increased morbidity, emergency events and reduced subjective health status. To further investigate general morbidity, hypocalcemic events, subjective and daily life performance in patients with chronic hypoparathyroidism a disease specific questionnaire, as well as the SF-36 are handed out.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Charite Berlin, Berlin, Germany
Design:
In a cross-sectional trial the subjective health status and burden of illness in patients with chronic hypoparathyroidism will be evaluated by using a disease specific questionnaire as well as the SF-36.
Patients:
Patients will be recruited out of the patient population of the participating five medical centers.
Statistical Analysis:
Documentation and analysis will be performed at the Department of Medicine I, Endocrine and Diabetes Unit, University of Würzburg, Germany. Data will be documented after pseudonymisation in a data base. For further analysis data will be compared to sex- and age-matched controls.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 - 24 months
Assessment of the burden of illness due to chronic hypoparathyroidism using a disease specific questionnaire to further investigate impairment in daily and professional life in comparison to the general German population (DEGS1, SHIP-2).
Time frame: 12 - 24 months
documentation of frequency of hypocalcemia under standard treatment
Time frame: 12 - 24 months
documentation of frequency of anxiety and depression under standard treatment
Time frame: 12-24 months
Assessment of the subjective health status due to chronic hypoparathyroidism by Assessment of subjective health status in patients with chronic hypoparathyroidism
University of Wuerzburg
Other
Burden of Illness and Disease Associated Emergencies in Chronic Hypoparathyroidism
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04701203
Endocrine System Diseases, Hypoparathyroidism
San Francisco, California, United States
View Trial DetailsNCT04009291
Endocrine System Diseases, Hypoparathyroidism
Chicago, Illinois, United States
View Trial DetailsNCT05387070
Endocrine System Diseases, Hypoparathyroidism
Beijing, Beijing Municipality, China
View Trial DetailsNCT05022667
Endocrine Gland Neoplasms, Endocrine System Diseases
Ann Arbor, Michigan, United States
View Trial Details